Literature DB >> 1771474

Notification of the sex and needle-sharing partners of individuals with human immunodeficiency virus in rural South Carolina: 30-month experience.

R F Wykoff1, J L Jones, S T Longshore, S L Hollis, C B Quiller, H Dowda, W B Gamble.   

Abstract

The authors conducted a confidential and voluntary partner notification program to identify and educate the sex and needle-sharing partners of individuals with the human immunodeficiency virus (HIV) in a rural health district in South Carolina. During the first 30 months, of 485 named contacts, 290 (60%) were residents of the health district and were contacted and offered testing. Of the 290 contacted, 280 (97%)--53 women and 227 men; age range 14-74 years--accepted counseling and testing and 49 (18%) were HIV-antibody positive. Only 3 of the 49 (6%) had been previously tested. All HIV-infected individuals received appropriate physician, laboratory, and public health referrals. During the study, the mean number of sex partners per 6-month period decreased from 5.6 to 1.1 (80% reduction) for HIV-antibody positive persons and from 4.0 to 2.0 (50% reduction) for HIV-antibody negative persons. The authors conclude that in a rural setting, partner notification of HIV exposure can accurately target education and testing and can produce positive behavior change.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771474     DOI: 10.1097/00007435-199110000-00004

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  11 in total

1.  Predictors of time spent on partner notification in four US sites.

Authors:  B A Macke; M H Hennessy; M McFarlane
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

2.  HIV seropositive drug users' attitudes towards partner notification (PCRS): results from the SHIELD study in Baltimore, Maryland.

Authors:  Karin E Tobin; Kathryn E Muessig; Carl A Latkin
Journal:  Patient Educ Couns       Date:  2007-04-20

3.  The Changing Role of Disease Intervention Specialists in Modern Public Health Programs.

Authors:  Anna B Cope; Victoria L Mobley; Erika Samoff; Kevin O'Connor; Thomas A Peterman
Journal:  Public Health Rep       Date:  2018-11-30       Impact factor: 2.792

4.  Partner Notification for Youth Living With HIV in 14 Cities in the United States.

Authors:  Jacob J van den Berg; Marjan Javanbakht; Pamina M Gorbach; Bret J Rudy; Andrew O Westfall; Craig M Wilson; Michelle A Lally
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

Review 5.  Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.

Authors:  Catherine E Paquette; Robin A Pollini
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

6.  Partner notification for HIV infection in Denmark: attitudes and preliminary results.

Authors:  A M Worm; E Smith; H Sørensen; H Haxholdt
Journal:  Genitourin Med       Date:  1996-08

7.  Mandated life versus mandatory death: New York's disgraceful partner notification record.

Authors:  C Norwood
Journal:  J Community Health       Date:  1995-04

8.  Partner notification for control of HIV: results after 2 years of a statewide program in Utah.

Authors:  A T Pavia; M Benyo; L Niler; I Risk
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

9.  HIV prevalence among clients attending a sexually transmitted diseases clinic in Amsterdam: the potential risk for heterosexual transmission.

Authors:  J S Fennema; E J van Ameijden; R A Coutinho; G J van Doornum; C J Henquet; J A van den Hoek
Journal:  Genitourin Med       Date:  1993-02

10.  Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries.

Authors:  Catherine Henley; Gideon Forgwei; Thomas Welty; Matthew Golden; Adaora Adimora; Raymond Shields; Pius Tih Muffih
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.